Science & Technology
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome
Department of Health and Human Services — National Institutes of Health
Opportunity #: 4R42HL166050-02
Award Ceiling
$887K
Award Floor
$887K
Close Date
Feb 28, 2027
350 days leftTotal Funding
$887K
Expected Awards
1
Posted Date
Mar 1, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-4R42HL166050-02
Description
STTR Phase Phase II award: "Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome" awarded to CMTX BIOTECH INC in KINGS PARK, New York. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $887,354. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.